If you have a certain type of leukemia, your doctor might suggest Tasigna (nilotinib) as a treatment option for you. As a result, you could be looking for more information about the drug, such as ...
STOCKHOLM--(BUSINESS WIRE)--Xspray Pharma AB (Stockholm/Nasdaq: XSPRAY), a biotechnology company focused on developing improved protein kinase inhibitors (PKIs) for cancer treatment using its ...
Tasigna (nilotinib) is a brand-name prescription medication. It’s approved by the Food and Drug Administration (FDA) to treat Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML).
Approval granted under priority review and is based on Novartis trials evaluating TFR with Tasigna in both the first-line and second-line settings Basel, December 22, 2017- Novartis announced today ...
Tasigna (nilotinib) is a brand-name prescription medication. The Food and Drug Administration (FDA) has approved it to treat certain forms of Philadelphia chromosome-positive (Ph+) chronic myeloid ...
The studies reinstated the superiority of Tasigna over Glivec in achieving deeper molecular responses across various patient populations affected by Philadelphia chromosome-positive chronic myeloid ...
EAST HANOVER, N.J., Feb. 19 Novartis announced today that Tasigna® (nilotinib) 200 mg capsules has been granted priority review by the US Food and Drug Administration (FDA) for the treatment of adult ...
Basel, March 22, 2018 - Novartis announced today that the US Food and Drug Administration (FDA) expanded the indication for Tasigna ® (nilotinib) to include treatment of first- and second-line ...
Novartis announced that Tasigna (nilotinib) 150 mg capsules have been approved by the FDA for the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid ...
Approval of Azurity Pharmaceuticals' Danziten allows patients with chronic myeloid leukemia to take nilotinib without having to fast. (iStock / Getty Images Plus) Azurity Pharmaceuticals has earned ...
E.l.i.a.s. (Reuters) - The Judicial Panel on Multidistrict Litigation on Tuesday consolidated new MDLs over Novartis AG's cancer drug Tasigna and Seresto brand flea and tick collars for pets, while ...
If you have chronic myeloid leukemia (CML) that’s Philadelphia chromosome-positive (Ph+), your doctor might suggest Tasigna (nilotinib) as a treatment option. It’s a prescription medication that’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results